This is not the only specialty whose practice conflicts with ASA guidelines
What This Means for You How the Weight-Loss Pathway Opened Up From Announcement to Live Program On November 6, 2025 , the Trump administration announced agreements with Eli Lilly and Novo Nordisk to expand Medicare coverage of GLP-1 medications (a class of weight loss and diabetes drugs including Wegovy, Ozempic, and Zepbound) for obesity
More studies are needed to find out if this is an adverse effect only in patients with diabetes or if people taking GLP-1 drugs for weight loss are also at risk, VanderBeek added
This thorough approach ensures that the treatment plan is personalized and effective
Our weight management programs for health plans combine science-backed behavioral care, personalized medication management, and configurable GLP-1 and Rx funding strategies to deliver effective obesity management at scale
We dont know if it improves egg quality, or if it harms egg quality